1 / 13

TOC - Global Aseptic Pharma Processing Market

The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.

bisreports
Download Presentation

TOC - Global Aseptic Pharma Processing Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. res Aseptic Pharma Processing Market – Global and Regional Analysis Table of Content GLOBAL ASEPTIC PHARMA PROCESSING MARKET Focus on Product, Technology, Regional and Country Analysis Analysis and Forecast: 2021-2031 December 2021 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. GLOBAL ASEPTIC PHARMA PROCESSING MARKET Copyright © 2021 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary ........................................................................ 13 1.Product Definition ..................................................................... 19 1.1 Inclusions ......................................................................................................... 19 Exclusions ........................................................................................................ 19 2.Scope of the Work .................................................................... 20 1.2 2.1 Overview: Report Scope ................................................................................. 20 2.2 Segmentation of the Global Aseptic Pharma Processing Market ............... 21 2.3 Assumptions and Limitations ......................................................................... 22 Key Questions Answered by this Report....................................................... 23 3.Research Methodology ............................................................. 24 2.4 3.1 Global Aseptic Pharma Processing Market: Research Methodology ......... 24 3.2 Primary Data Sources ..................................................................................... 25 3.3 Secondary Data Sources ................................................................................ 26 3.4 Market Estimation Model................................................................................. 26 Criteria for Company Profiling ........................................................................ 27 4.Markets .................................................................................... 28 3.5 4.1 Market Overview .............................................................................................. 29 4.2 Global Aseptic Pharma Processing Market: Future Potential ..................... 30 4.2.1Ecosystem Participants .............................................................................. 30 GLOBAL ASEPTIC PHARMA PROCESSING MARKET 4.3 Impact of COVID-19 on the Global Aseptic Pharma Processing Market ........................................................................................................................... 31 4.3.1Patent Analysis ............................................................................................ 32 4.3.1.1 Introduction ...................................................................................................... 32 4.3.1.2 Patent Landscape ............................................................................................ 32 5.Global Aseptic Pharma Processing Market: Industry Analysis ... 33 5.1 Overview ........................................................................................................... 33 5.2 Policies and Regulatory Framework .............................................................. 33 5.2.1Overview ...................................................................................................... 33 5.2.2Regulatory Framework in the U.S. ............................................................. 33 3 All rights reserved at BIS Research Inc.

  4. 5.2.3Regulatory Framework in EU4 (Germany, France, Italy, Spain) and the U.K. ......................................................................................................... 34 5.2.4Regulatory Framework in Asia-Pacific ...................................................... 35 5.3 Market Dynamics ............................................................................................. 36 5.3.1Reduced Risk of High-Cost Product Loss ................................................ 36 5.3.2High Growth in the Generics and Biopharmaceuticals Markets ............. 37 5.3.3Growing Demand for Contract Manufacturing Organizations (CMOs) for Aseptic Manufacturing of Pharmaceutical Products ............ 37 5.4 Market Challenges ........................................................................................... 38 5.4.1High Capital Investment .............................................................................. 38 5.4.2Lack of Skilled Personnel ........................................................................... 38 5.5 Market Opportunities ....................................................................................... 39 5.5.1Emergence of Data within the Aseptic Processing Industry ................... 39 5.5.2Growing Demand for Automated Products in Aseptic Pharma Processing at the Pharmaceutical Companies ......................................... 39 5.5.3Increasing Investment in R&D .................................................................... 40 5.5.4Competitive Landscape .............................................................................. 40 5.6 New Offerings .................................................................................................. 41 5.7 Funding and Investments ............................................................................... 42 5.8 Mergers and Acquisitions ............................................................................... 43 5.9 Synergistic Activities ...................................................................................... 43 GLOBAL ASEPTIC PHARMA PROCESSING MARKET 5.10Market Share Analysis, By Company ............................................................. 44 6.Technology .............................................................................. 46 6.1 Global Aseptic Pharma Processing Market (by Technology) ...................... 47 6.1.1Drying ........................................................................................................... 47 6.1.2Lyophilization .............................................................................................. 48 6.1.3Closed Vial Technology .............................................................................. 49 6.1.4Blow-Fill-Seal Technology .......................................................................... 50 6.1.5Others ........................................................................................................... 51 7.Products .................................................................................. 53 4 All rights reserved at BIS Research Inc.

  5. 7.1 Global Aseptic Pharma Processing Market (by Product) ............................. 54 7.1.1Corticosteroids ............................................................................................ 54 7.1.2Long-Acting Beta Agonists/Long-Acting Muscarinic Antagonists ......... 55 7.1.3Antibiotics .................................................................................................... 56 7.1.4Others ........................................................................................................... 56 8.Region ..................................................................................... 58 8.1 North America .................................................................................................. 60 8.1.1U.S. ............................................................................................................... 61 8.1.2Canada ......................................................................................................... 62 8.2 Europe .............................................................................................................. 63 8.2.1Germany ....................................................................................................... 65 8.2.2U.K. ............................................................................................................... 65 8.2.3France ........................................................................................................... 66 8.2.4Italy ............................................................................................................... 67 8.2.5Spain ............................................................................................................. 68 8.2.6Rest-of-Europe............................................................................................. 69 8.3 Asia-Pacific ...................................................................................................... 70 8.3.1Market Dynamics ......................................................................................... 71 8.3.2Japan ............................................................................................................ 72 8.3.3China ............................................................................................................ 73 GLOBAL ASEPTIC PHARMA PROCESSING MARKET 8.3.4India .............................................................................................................. 74 8.3.5Australia ....................................................................................................... 75 8.3.6South Korea ................................................................................................. 76 8.3.7Rest-of-Asia-Pacific ..................................................................................... 77 Rest-of-the-World ............................................................................................ 78 9. Markets - Competitive Benchmarking & Company Profiles ........ 79 8.4 9.1 Company Profile .............................................................................................. 80 9.2 Abbvie Inc. ........................................................................................................ 81 9.2.1Company Overview ..................................................................................... 81 9.2.1.1 Role of Abbvie Inc. in Global Aseptic Pharma Processing Market .................... 81 5 All rights reserved at BIS Research Inc.

  6. 9.2.1.2 Abbvie Inc.: Product Portfolio ........................................................................... 82 9.2.2Financials ..................................................................................................... 82 9.2.3SWOT Analysis ............................................................................................ 84 9.3 Lonza Group ..................................................................................................... 85 9.3.1Company Overview ..................................................................................... 85 9.3.1.1 Role of Lonza Group in Global Aseptic Pharma Processing Market ................. 85 9.3.1.2 Lonza Group : Product Portfolio ....................................................................... 85 9.3.2Financials ..................................................................................................... 86 9.3.3SWOT Analysis ............................................................................................ 87 9.4 Baxter International Inc. .................................................................................. 88 9.4.1Company Overview ..................................................................................... 88 9.4.1.1 Role of Baxter International Inc. in the Global Aseptic Pharma Processing Market .............................................................................................................. 88 9.4.1.2 Baxter International Inc. : Product Portfolio ...................................................... 89 9.4.2Financials ..................................................................................................... 89 9.4.3SWOT Analysis ............................................................................................ 92 9.5 August Bioservices ......................................................................................... 93 9.5.1Company Overview ..................................................................................... 93 9.5.1.1 Role of August Bioservices in the Global Aseptic Pharma Processing Market .............................................................................................................. 93 GLOBAL ASEPTIC PHARMA PROCESSING MARKET 9.5.1.2 August Bioservices: Product Portfolio ............................................................... 93 9.5.2SWOT Analysis ............................................................................................ 94 9.6 Vetter Pharma .................................................................................................. 95 9.6.1Company Overview ..................................................................................... 95 9.6.1.1 Role of Vetter Pharma in Global Aseptic Pharma Processing Market ............... 95 9.6.1.2 Vetter Pharma : Product Portfolio ..................................................................... 95 9.6.2SWOT Analysis ............................................................................................ 96 9.7 Recipharm AB .................................................................................................. 97 9.7.1Company Overview ..................................................................................... 97 9.7.1.1 Role of Recipharm AB in Global Aseptic Pharma Processing Market ............... 97 6 All rights reserved at BIS Research Inc.

  7. 9.7.2SWOT Analysis ............................................................................................ 99 9.8 Berkshire Sterile Manufacturing ................................................................... 100 9.8.1Company Overview ................................................................................... 100 9.8.1.1 Role of Berkshire Sterile Manufacturing in Global Aseptic Pharma Processing Market ......................................................................................... 100 9.8.2SWOT Analysis .......................................................................................... 101 9.9 Recro Pharma ................................................................................................ 102 9.9.1Company Overview ................................................................................... 102 9.9.1.1 Role of Recro Pharma in Global Aseptic Pharma Processing Market ............. 102 9.9.2SWOT Analysis .......................................................................................... 103 9.10Curia ............................................................................................................... 104 9.10.1Company Overview ................................................................................... 104 9.10.1.1 Role of Curia in Global Aseptic Pharma Processing Market ........................... 104 9.10.2SWOT Analysis .......................................................................................... 105 9.11Samsung Biologics ....................................................................................... 106 9.11.1Company Overview ................................................................................... 106 9.11.1.1 Role of Samsung Biologics in the Global Aseptic Pharma Processing Market ............................................................................................................ 106 9.11.1.2 Samsung Biologics : Overall Product Portfolio................................................ 106 9.11.2Financials ................................................................................................... 107 GLOBAL ASEPTIC PHARMA PROCESSING MARKET 9.11.3SWOT Samsung Biologics Analysis ........................................................ 108 9.12Symbiosis Pharmaceutical Services ............................................................ 109 9.12.1Company Overview ................................................................................... 109 9.12.1.1 Role of Symbiosis Pharmaceutical Services in the Global Aseptic Pharma Market ............................................................................................................ 109 9.12.1.2 Symbiosis Pharmaceutical Services: Overall Product Portfolio ....................... 109 9.12.2SWOT Analysis .......................................................................................... 110 9.13Catalent Pharma Solutions Inc. .................................................................... 111 9.13.1Company Overview ................................................................................... 111 9.13.1.1 Role of Catalent Pharma Solutions Inc.in the Global Aseptic Pharma Market ............................................................................................................ 111 7 All rights reserved at BIS Research Inc.

  8. 9.13.1.2 Catalent Pharma Solutions Inc.: Overall Product Portfolio ............................. 112 9.13.2Financials ................................................................................................... 112 9.13.3SWOT Analysis .......................................................................................... 115 9.14Alcami Corporation ....................................................................................... 116 9.14.1Company Overview ................................................................................... 116 9.14.1.1 Role of Alcami Corporation in the Global Aseptic Pharma Market .................. 116 9.14.1.2 Alcami Corporation : Overall Product Portfolio................................................ 116 9.14.2SWOT Analysis .......................................................................................... 117 9.15Wuxi AppTec .................................................................................................. 118 9.15.1Company Overview ................................................................................... 118 9.15.2Role of Wuxi AppTec in the Global Aseptic Pharma Processing Market ......................................................................................................... 118 9.15.3Financials ................................................................................................... 119 9.15.4Key Insights About Financial Health of the Company ........................... 121 9.15.5SWOT Analysis .......................................................................................... 122 GLOBAL ASEPTIC PHARMA PROCESSING MARKET 8 All rights reserved at BIS Research Inc.

  9. List of Figures Figure 1:Global COVID-19 Vaccination Scenario (2021) Figure 2:Global Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 3:Global Aseptic Pharma Processing Market: Impact Analysis Figure 4:Global Aseptic Pharma Processing Market (by Product Type), $Million, 2020, 2025 and 2031 Figure 5:Global Aseptic Pharma Processing Market (by Technology), $Million, 2020, 2025, and2031 Figure 6:Global Aseptic Pharma Processing Market (by Region), 2020 and 2031 Figure 7:Share of Key Market Strategies and Developments, January 2017- December 2021 Figure 8:Global Aseptic Pharma Processing Market (by Segment) Figure 9:Global Aseptic Pharma Processing Market Methodology Figure 10:Figure 3.2: Primary Research Methodology Figure 11:Bottom-Up Approach (Segment-Wise Analysis) Figure 12:Global Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 13:Ecosystem: CDMOs Figure 14:Impact of COVID-19 on the Global Aseptic Pharma Processing Market, $Million, 2020-2026 Figure 15:Patent Analysis (by Year), 2018-2021 Figure 16:Global Aseptic Pharma Processing Market, Business Dynamics Figure 17:Share of Key Market Strategies and Developments, January 2017- December 2021 Figure 18:Share of New Offerings (by Company), January 2017- December 2021 Figure 19:Share of Fundings and Investments (by Company), January 2017- December 2021 Figure 20:Share of Mergers and Acquisitions (by Company), January 2017- December 2021 GLOBAL ASEPTIC PHARMA PROCESSING MARKET Figure 21:Share of Synergistic Activities (by Company), January 2017- December 2021 Figure 22:Market Share Analysis for Global Aseptic Pharma Processing Market, 2020 Figure 23:Global Aseptic Pharma Processing Market (by Technology) Figure 24:Global Aseptic Pharma Processing Market (Drying), $Million, 2020-2031 Figure 25:Global Aseptic Pharma Processing Market (Lyophilization), $Million, 2020-2031 Figure 26:: Global Aseptic Pharma Processing Market (Closed Vial Technology), $Million, 2020-2031 Figure 27:: Global Aseptic Pharma Processing Market (Blow-Fill-Seal Technology), $Million, 2020-2031 Figure 28:Global Aseptic Pharma Processing Market (Others), $Million, 2020-2031 Figure 29:Global Aseptic Pharma Processing Market (by Product) Figure 30:: Global Aseptic Pharma Processing Market (Corticosteroids), $Million, 2020-2031 9 All rights reserved at BIS Research Inc.

  10. Figure 31:Global Aseptic Pharma Processing Market (Long-Acting Muscarinic Antagonists), $Million, 2020- 2031 Figure 32:Global Aseptic Pharma Processing Market (Antibiotics), $Million, 2020-2031 Figure 33:Global Aseptic Pharma Processing Market (Others), $Million, 2020-2031 Figure 34:Global Aseptic Pharma Processing Market (by Region), 2020-2031 Figure 35:Share of North America Aseptic Pharma Processing Market Revenue (by Country), $Million, 2020 and 2031 Figure 36:North America: Market Dynamics Figure 37:U.S. Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 38:Canada Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 39:Share of Europe Aseptic Pharma Processing Market (by Country), $Million, 2021-2031 Figure 40:Europe: Market Dynamics Figure 41:Germany Aseptic Pharma Processing Market Revenue, $Million, 2020-2031 Figure 42:U.K. Pharma Processing Market Revenue, $Million, 2020-2031 Figure 43:France Pharma Processing Market Revenue, $Million, 2020-2031 Figure 44:Italy Pharma Processing Market Revenue, $Million, 2020-2031 Figure 45:Spain Pharma Processing Market Revenue, $Million, 2020-2031 Figure 46:Rest-of-Europe Pharma Processing Market Revenue, $Million, 2020-2031 Figure 47:Asia-Pacific Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 48:Asia-Pacific: Market Dynamics Figure 49:Revenue Contributions of Various Countries in Asia-Pacific, $Million, 2020 and 2031 Figure 50:Japan Aseptic Pharma Processing Market, $Million, 2020-2031 GLOBAL ASEPTIC PHARMA PROCESSING MARKET Figure 51:China Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 52:India Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 53:Australia Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 54:South Korea Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 55:Rest-of-APAC Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 56:Rest-of-the-World Aseptic Pharma Processing Market, $Million, 2020-2031 Figure 57:Shares of Key Company Profiles Figure 58:Abbvie, Inc.: Overall Financials, $Million, 2018-2020 Figure 59:Abbvie, Inc.: Revenue (by Region), $Million, 2018-2020 Figure 60:Abbvie, Inc.: R&D Expenditure, $Million, 2018-2020 Figure 61:Abbvie, Inc.: SWOT Analysis 10 All rights reserved at BIS Research Inc.

  11. Figure 62:Lonza Group: Overall Financials, $Million, 2018-2020 Figure 63:Lonza Group: R&D Expenditure, $Million, 2018-2020 Figure 64:Lonza Group: SWOT Analysis Figure 65:Baxter International Inc.: Overall Financials, $Million, 2018-2020 Figure 66:Baxter International Inc. Revenue (by Segment), $Million, 2018-2020 Figure 67:Baxter International Inc. Revenue (by Region), $Million, 2018-2020 Figure 68:Baxter International Inc.: R&D Expenditure, $Million, 2018-2020 Figure 69:Baxter International Inc.: SWOT Analysis Figure 70:August Bioservices: SWOT Analysis Figure 71:Vetter Pharma: SWOT Analysis Figure 72:Recipharm AB: Overall Product Portfolio Figure 73:Recipharm AB: SWOT Analysis Figure 74:Berkshire Sterile Manufacturing: Overall Product Portfolio Figure 75:Berkshire Sterile Manufacturing: SWOT Analysis Figure 76:Recro Pharma : Overall Product Portfolio Figure 77:Recro Pharma: SWOT Analysis Figure 78:Curia: Overall Product Portfolio Figure 79:Curia: SWOT Analysis Figure 80:Samsung Biologics: Overall Financials, $Million, 2018-2020 Figure 81:Samsung Biologics Revenue (by Region), $Million, 2018-2020 Figure 82:Samsung Biologics: SWOT Analysis Figure 83:Symbiosis Pharmaceutical Services: SWOT Analysis GLOBAL ASEPTIC PHARMA PROCESSING MARKET Figure 84:Catalent Pharma Solutions Inc: Overall Financials, 2019-2021 Figure 85:Catalent Pharma Solutions Inc: Company Revenue (by Segments), 2019-2021 Figure 86:Catalent Pharma Solutions Inc.: R&D Expenditure, 2019-2021 Figure 87:Catalent Pharma Solutions Inc.: SWOT Analysis Figure 88:Alcami Corporation: SWOT Analysis Figure 89:Wuxi AppTec: Overall Product Portfolio Figure 90:Wuxi AppTec: Overall Financials, 2018-2020 Figure 91:Wuxi AppTec: Revenue (by Segment), 2018-2020 Figure 92:Wuxi AppTec: Revenue (by Region), 2018-2020 Figure 93:Wuxi AppTec: R&D Expenditure, 2018-2020 Figure 94:Wuxi AppTec: SWOT Analysis 11 All rights reserved at BIS Research Inc.

  12. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 GLOBAL ASEPTIC PHARMA PROCESSING MARKET 12 All rights reserved at BIS Research Inc.

  13. GLOBAL ASEPTIC PHARMA PROCESSING MARKET BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com 13 All rights reserved at BIS Research Inc.

More Related